Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells. | J Radiat Res | 2022 | 35589101 | PubTator, text mining | PubMed |
| Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses. | Nat Commun | 2022 | 35577786 | PubTator, text mining | PubMed |
| High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome. | Cancers (Basel) | 2022 | 35565214 | PubTator, text mining | PubMed |
| Non-AUG translation initiation in mammals. | Genome Biol | 2022 | 35534899 | PubTator, text mining | PubMed |
| eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors. | Mol Cell Proteomics | 2022 | 35513296 | PubTator, text mining | PubMed |
| A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism. | Patterns (N Y) | 2022 | 35510183 | PubTator, text mining | PubMed |
| Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages. | Nat Commun | 2022 | 35508466 | PubTator, text mining | PubMed |
| Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer. | Clin Cancer Res | 2022 | 35507014 | PubTator, text mining | PubMed |
| Role of p38 MAP kinase in cancer stem cells and metastasis. | Oncogene | 2022 | 35501462 | PubTator, text mining | PubMed |
| Transcriptomic Changes of Photoperiodic Response in the Hypothalamus Were Identified in Ovariectomized and Estradiol-Treated Sheep. | Front Mol Biosci | 2022 | 35480892 | PubTator, text mining | PubMed |
| Characterization of Plasma Extrachromosomal Circular DNA in Gouty Arthritis. | Front Genet | 2022 | 35464862 | PubTator, text mining | PubMed |
| Proline Metabolism in Malignant Gliomas: A Systematic Literature Review. | Cancers (Basel) | 2022 | 35454935 | PubTator, text mining | PubMed |
| Preclinical studies for improving radiosensitivity of non-small cell lung cancer cell lines by combining glutaminase inhibition and senolysis. | Transl Oncol | 2022 | 35452996 | PubTator, text mining | PubMed |
| Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK-STAT signaling in macrophages by perturbing lipid raft structures. | Mol Oncol | 2022 | 35451191 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet. | BMC Bioinformatics | 2022 | 35439941 | PubTator, text mining | PubMed |
| Construction of a circRNA-Mediated ceRNA Network Reveals Novel Biomarkers for Aortic Dissection. | Int J Gen Med | 2022 | 35437351 | PubTator, text mining | PubMed |
| Metastasis and MAPK Pathways. | Int J Mol Sci | 2022 | 35409206 | PubTator, text mining | PubMed |
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. | Int J Mol Sci | 2022 | 35409008 | PubTator, text mining | PubMed |
| Porphyromonas gingivalis W83 Membrane Components Induce Distinct Profiles of Metabolic Genes in Oral Squamous Carcinoma Cells. | Int J Mol Sci | 2022 | 35408801 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=20